Patients with rheumatoid arthritis are more likely to experience flares during the early postpartum period than during ...

New guidelines from two leading medical associations suggest that efforts to reduce bad cholesterol should focus on ...

A quantum tech firm that has collaborated with—and received investment from—Amgen is now planning to go public. | A quantum ...

In this video from the American Academy of Dermatology Annual Meeting, April W. Armstrong, MD, MPH, discusses data presented ...

Diagnosed at a pivotal moment in early adulthood, William underwent a range of treatments over the course of three years, ...

Dr. Howard Chang, fourth from left, Amgen's senior vice president global research & chief scientific officer, with fellows in the biotech company's new postbaccalaureate fellowship program. The ...

In this video from the American Academy of Dermatology Annual Meeting, Lawrence F. Eichenfield, MD, discusses new treatment ...

In this GEN webinar, Joseph Shultz (VP of technical development and manufacturing, Ottimo Pharma) and Imroz Ghangas (VP of commercial sales, Asimov) discuss strategies for achieving high-performing ...

Nona Biosciences ("Nona" or the "Company"), a global biotechnology company advancing biotherapeutic discovery through ...

On Wednesday evening, DIA presents its Inspire Awards at the National Constitution Center honoring Noubar Afeyan, Peter Marks ...

Repatha’s withdrawal from Denmark is best understood as an early signal of the impact of Most Favored Nation drug pricing ...

A BMS spokesperson confirmed the Phase III trial, which would have converted an accelerated approval into full approval if successful, failed to meet its primary endpoint.